167 related articles for article (PubMed ID: 38198137)
1. Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer.
Cosentini D; Pedersini R; Di Mauro P; Zamparini M; Schivardi G; Rinaudo L; Di Meo N; Delbarba A; Cappelli C; Laganà M; Alberti A; Baronchelli M; Guerci G; Laini L; Grisanti S; Simoncini EL; Farina D; Mazziotti G; Berruti A;
JAMA Netw Open; 2024 Jan; 7(1):e2350950. PubMed ID: 38198137
[TBL] [Abstract][Full Text] [Related]
2. Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy.
Pedersini R; Amoroso V; Maffezzoni F; Gallo F; Turla A; Monteverdi S; Ardine M; Ravanelli M; Vassalli L; Rodella F; Formenti AM; Dalla Volta A; Simoncini EL; Giustina A; Maroldi R; Berruti A
JAMA Netw Open; 2019 Sep; 2(9):e1911080. PubMed ID: 31560383
[TBL] [Abstract][Full Text] [Related]
3. The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy.
Monteverdi S; Pedersini R; Gallo F; Maffezzoni F; Dalla Volta A; Di Mauro P; Turla A; Vassalli L; Ardine M; Formenti AM; Simoncini EL; Giustina A; Maroldi R; Amoroso V; Berruti A
JBMR Plus; 2021 Feb; 5(2):e10440. PubMed ID: 33615109
[TBL] [Abstract][Full Text] [Related]
4. Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study.
Pedersini R; Cosentini D; Rinaudo L; Zamparini M; Ulivieri FM; di Mauro P; Maffezzoni F; Monteverdi S; Vena W; Laini L; Amoroso V; Simoncini EL; Farina D; Mazziotti G; Berruti A
Bone Rep; 2023 Jun; 18():101654. PubMed ID: 36700242
[TBL] [Abstract][Full Text] [Related]
5. Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors.
Mazziotti G; Pedersini R; Vena W; Cosentini D; Carrone F; Pigni S; Simoncini EL; Torrisi R; Zambelli A; Farina D; Balzarini L; Lania AG; Berruti A
Calcif Tissue Int; 2022 Nov; 111(5):466-474. PubMed ID: 35902384
[TBL] [Abstract][Full Text] [Related]
6. Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S; Pedersini R; Birtolo MF; Baruch NL; Carrone F; Jaafar S; Ciafardini A; Cosentini D; Laganà M; Torrisi R; Farina D; Leonardi L; Balzarini L; Vena W; Bossi AC; Zambelli A; Lania AG; Berruti A; Mazziotti G
J Endocrinol Invest; 2024 Feb; 47(2):433-442. PubMed ID: 37592052
[TBL] [Abstract][Full Text] [Related]
7. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
Pedersini R; Monteverdi S; Mazziotti G; Amoroso V; Roca E; Maffezzoni F; Vassalli L; Rodella F; Formenti AM; Frara S; Maroldi R; Berruti A; Simoncini E; Giustina A
Bone; 2017 Apr; 97():147-152. PubMed ID: 28104509
[TBL] [Abstract][Full Text] [Related]
8. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
9. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M; Pfeiler G; Dubsky PC; Hubalek M; Greil R; Jakesz R; Wette V; Balic M; Haslbauer F; Melbinger E; Bjelic-Radisic V; Artner-Matuschek S; Fitzal F; Marth C; Sevelda P; Mlineritsch B; Steger GG; Manfreda D; Exner R; Egle D; Bergh J; Kainberger F; Talbot S; Warner D; Fesl C; Singer CF;
Lancet; 2015 Aug; 386(9992):433-43. PubMed ID: 26040499
[TBL] [Abstract][Full Text] [Related]
11. Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome.
Vena W; Carrone F; Delbarba A; Akpojiyovbi O; Pezzaioli LC; Facondo P; Cappelli C; Leonardi L; Balzarini L; Farina D; Pizzocaro A; Lania AG; Mazziotti G; Ferlin A
J Endocrinol Invest; 2023 Feb; 46(2):297-304. PubMed ID: 36030302
[TBL] [Abstract][Full Text] [Related]
12. Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
Gonzalez-Rodriguez E; Aubry-Rozier B; Stoll D; Zaman K; Lamy O
Breast Cancer Res Treat; 2020 Jan; 179(1):153-159. PubMed ID: 31598815
[TBL] [Abstract][Full Text] [Related]
13. Grade 1 Vertebral Fractures Identified by Densitometric Lateral Spine Imaging Predict Incident Major Osteoporotic Fracture Independently of Clinical Risk Factors and Bone Mineral Density in Older Women.
Johansson L; Sundh D; Magnusson P; Rukmangatharajan K; Mellström D; Nilsson AG; Lorentzon M
J Bone Miner Res; 2020 Oct; 35(10):1942-1951. PubMed ID: 32539162
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for the efficacy of denosumab in postmenopausal Japanese women with non-metastatic breast cancer receiving adjuvant aromatase inhibitors: a combined analysis of two prospective clinical trials.
Nakatsukasa K; Koyama H; Ouchi Y; Sakaguchi K; Fujita Y; Matsuda T; Kato M; Konishi E; Taguchi T
J Bone Miner Metab; 2019 Sep; 37(5):864-870. PubMed ID: 30868270
[TBL] [Abstract][Full Text] [Related]
15. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
[TBL] [Abstract][Full Text] [Related]
16. Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab.
Catalano A; Gaudio A; Morabito N; Basile G; Agostino RM; Xourafa A; Atteritano M; Morini E; Natale G; Lasco A
J Endocrinol Invest; 2017 Aug; 40(8):851-857. PubMed ID: 28332172
[TBL] [Abstract][Full Text] [Related]
17. Early Denosumab for the prevention of osteoporotic fractures in breast cancer women undergoing aromatase inhibitors: A case-control retrospective study.
Scaturro D; de Sire A; Terrana P; Curci C; Vitagliani F; Falco V; Cuntrera D; Iolascon G; Mauro GL
J Back Musculoskelet Rehabil; 2022; 35(1):207-212. PubMed ID: 34092604
[TBL] [Abstract][Full Text] [Related]
18. The Prevalence of Vertebral Fractures Is Associated With Reduced Hip Bone Density and Inferior Peripheral Appendicular Volumetric Bone Density and Structure in Older Women.
Johansson L; Sundh D; Zoulakis M; Rudäng R; Darelid A; Brisby H; Nilsson AG; Mellström D; Lorentzon M
J Bone Miner Res; 2018 Feb; 33(2):250-260. PubMed ID: 28926125
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and incidence of vertebral fractures: a 7-year follow-up study in institutionalized adults with refractory epilepsy and intellectual disability.
Berkvens J; Majoie M; Mergler S; Beerhorst K; Verschuure P; Tan I; den Bergh JV
Epilepsy Res; 2020 Nov; 167():106461. PubMed ID: 32949979
[TBL] [Abstract][Full Text] [Related]
20. Performance of HR-pQCT, DXA, and FRAX in the discrimination of asymptomatic vertebral fracture in postmenopausal Chinese women.
Huang M; Hung VW; Li TK; Law SW; Wang Y; Chen S; Qin L
Arch Osteoporos; 2021 Sep; 16(1):125. PubMed ID: 34480663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
